387 related articles for article (PubMed ID: 32929366)
21. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
[TBL] [Abstract][Full Text] [Related]
22. The association between tau PET and retrospective cortical thinning in clinically normal elderly.
LaPoint MR; Chhatwal JP; Sepulcre J; Johnson KA; Sperling RA; Schultz AP
Neuroimage; 2017 Aug; 157():612-622. PubMed ID: 28545932
[TBL] [Abstract][Full Text] [Related]
23. The Imaging Features and Clinical Associations of a Novel Tau PET Tracer-18F-APN1607 in Alzheimer Disease.
Hsu JL; Lin KJ; Hsiao IT; Huang KL; Liu CH; Wu HC; Weng YC; Huang CY; Chang CC; Yen TC; Higuchi M; Jang MK; Huang CC
Clin Nucl Med; 2020 Oct; 45(10):747-756. PubMed ID: 32701794
[TBL] [Abstract][Full Text] [Related]
24. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
Ghisays V; Goradia DD; Protas H; Bauer RJ; Devadas V; Tariot PN; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Caselli RJ; Su Y; Chen K; Reiman EM
Alzheimers Dement; 2020 Apr; 16(4):598-609. PubMed ID: 31831374
[TBL] [Abstract][Full Text] [Related]
25. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
[TBL] [Abstract][Full Text] [Related]
26. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
[TBL] [Abstract][Full Text] [Related]
27. Association of
Du J; Li A; Shi D; Chen X; Wang Q; Liu Z; Sun K; Guo T;
Neurology; 2023 Jul; 101(1):e40-e49. PubMed ID: 37188537
[TBL] [Abstract][Full Text] [Related]
28. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
[TBL] [Abstract][Full Text] [Related]
29. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
[TBL] [Abstract][Full Text] [Related]
30. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
32. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
[TBL] [Abstract][Full Text] [Related]
33. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
34. Predicting diagnosis and cognition with
Mattsson N; Insel PS; Donohue M; Jögi J; Ossenkoppele R; Olsson T; Schöll M; Smith R; Hansson O
Alzheimers Dement; 2019 Apr; 15(4):570-580. PubMed ID: 30639421
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.
Das SR; Xie L; Wisse LEM; Ittyerah R; Tustison NJ; Dickerson BC; Yushkevich PA; Wolk DA;
Neurobiol Aging; 2018 Jun; 66():49-58. PubMed ID: 29518752
[TBL] [Abstract][Full Text] [Related]
36. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
Risacher SL; Kim S; Shen L; Nho K; Foroud T; Green RC; Petersen RC; Jack CR; Aisen PS; Koeppe RA; Jagust WJ; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
Front Aging Neurosci; 2013; 5():11. PubMed ID: 23554593
[TBL] [Abstract][Full Text] [Related]
37. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
Singh NA; Tosakulwong N; Graff-Radford J; Machulda MM; Pham NTT; Sintini I; Weigand SD; Schwarz CG; Senjem ML; Carrasquillo MM; Ertekin-Taner N; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Alzheimers Dement; 2022 Jun; ():. PubMed ID: 35691047
[TBL] [Abstract][Full Text] [Related]
38. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
40. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
